Brand History

Jellice Co., Ltd. is established with a focus on gelatin production and protein science. Early work refining collagen-based materials laid the foundation for decades of research into collagen structure and function.

On September 10, 1993, Dr. Yasuo Sakai filed a patent related to Collagen Tripeptide (CTP), marking a decisive step in Jellice’s pursuit of more precise collagen technology.

Researchers had long understood collagen’s importance to skin structure, but its complex molecular size limited how effectively it could be utilized. Through focused experimentation, Jellice scientists began isolating smaller collagen units, ultimately identifying Collagen Tripeptide, composed of just three amino acids.

This molecular refinement opened new scientific questions and possibilities. Continued research throughout the late 1990s helped clarify how collagen tripeptides could support collagen metabolism and skin function, establishing a foundation for future applications in beauty, wellness, and topical skincare innovation.

Jellice expanded its collagen research partnerships and production capabilities internationally, establishing a presence across Europe, Taiwan, India, and China. During this period, scientific studies continued to explore the biological activity of collagen tripeptides and their ability to support collagen synthesis, hydration, and skin elasticity — helping shape their future role in skincare innovation.

Clinical and laboratory studies further examined the effects of collagen tripeptides on skin health and aging, reinforcing their potential role in supporting skin hydration, elasticity, and overall skin structure.

Building on decades of collagen research, Jellice began applying Collagen Tripeptide technology to topical skincare formulations designed to support hydration, firmness, and skin renewal.

Jellice introduces its skincare line to the U.S. market, bringing Japanese collagen science and patented Collagen Tripeptide technology to consumers seeking research-driven skincare.